🇬🇧·Jun 11Research
First CD123-targeted ADC secures FDA approval for rare blood cancer
Publisher
N
Nature Reviews Drug Discovery
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Nature Reviews Drug Discovery
- Region
- UK
- Scope
- Research
- Published
- June 11, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on nature.com
Leave the platform to read the original full article on the publisher site.
Source: Nature Reviews Drug Discovery
Scope: Research
Related coverage
More related coverage
Universitätsklinikum Heidelberg/5h ago
COPLANT-Studie begrüßt 3.000. Teilnehmerin in Heidelberg
Northwestern Medicine/8h ago
Suburban Woman Reclaims Her Voice with Help from the Northwestern Medicine Aphasia Center at Marianjoy Rehabilitation Hospital
Universitätsklinikum Heidelberg/9h ago
Chronische Darmbeschwerden: Von der Diagnose zur modernen Therapie
UNMC/10h ago